BlackRock’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $124K | Buy |
71,542
+71,326
| +33,021% | +$346K | ﹤0.01% | 4958 |
|
|
2026
Q1 | $1.87K | Sell |
216
-212
| -50% | -$4.48K | ﹤0.01% | 5527 |
|
|
2025
Q4 | $11.9K | Hold |
428
| – | – | ﹤0.01% | 5274 |
|
|
2025
Q3 | $32.8K | Buy |
428
+1
| +0.2% | +$496 | ﹤0.01% | 5057 |
|
|
2025
Q2 | $102K | Hold |
427
| – | – | ﹤0.01% | 4836 |
|
|
2025
Q1 | $122K | Hold |
427
| – | – | ﹤0.01% | 4722 |
|
|
2024
Q4 | $148K | Hold |
427
| – | – | ﹤0.01% | 4681 |
|
|
2024
Q3 | $122K | Hold |
427
| – | – | ﹤0.01% | 4636 |
|
|
2024
Q2 | $151K | Sell |
427
-117
| -22% | -$38.7K | ﹤0.01% | 4603 |
|
|
2024
Q1 | $217K | Sell |
544
-2
| -0.4% | -$743 | ﹤0.01% | 4562 |
|
|
2023
Q4 | $191K | Buy |
546
+24
| +5% | +$8.49K | ﹤0.01% | 4650 |
|
|
2023
Q3 | $232K | Sell |
522
-4
| -0.8% | -$2.63K | ﹤0.01% | 4636 |
|
|
2023
Q2 | $384K | Buy |
526
+98
| +23% | +$76.1K | ﹤0.01% | 4559 |
|
|
2023
Q1 | $322K | Buy |
428
+114
| +36% | +$99.4K | ﹤0.01% | 4652 |
|
|
2022
Q4 | $599K | Sell |
314
-1
| -0.3% | -$396 | ﹤0.01% | 4565 |
|
|
2022
Q3 | $175K | Sell |
315
-3
| -0.9% | -$2.36K | ﹤0.01% | 5007 |
|
|
2022
Q2 | $238K | Sell |
318
-934
| -75% | -$1.47M | ﹤0.01% | 4992 |
|
|
2022
Q1 | $4.32M | Sell |
1,252
-3
| -0.2% | -$7.86K | ﹤0.01% | 4045 |
|
|
2021
Q4 | $3.79M | Sell |
1,255
-212
| -14% | -$984K | ﹤0.01% | 4117 |
|
|
2021
Q3 | $9.6M | Sell |
1,467
-22
| -1% | -$190K | ﹤0.01% | 3694 |
|
|
2021
Q2 | $19.7M | Buy |
1,489
+161
| +12% | +$2.53M | ﹤0.01% | 3317 |
|
|
2021
Q1 | $22.4M | Buy |
1,328
+63
| +5% | +$1.23M | ﹤0.01% | 3128 |
|
|
2020
Q4 | $21.4M | Buy |
1,265
+237
| +23% | +$4.46M | ﹤0.01% | 2969 |
|
|
2020
Q3 | $19.3M | Sell |
1,028
-99
| -9% | -$2.28M | ﹤0.01% | 2874 |
|
|
2020
Q2 | $29.6M | Buy |
1,127
+494
| +78% | +$14M | ﹤0.01% | 2592 |
|
|
2020
Q1 | $13.9M | Buy |
633
+63
| +11% | +$1.01M | ﹤0.01% | 2807 |
|
|
2019
Q4 | $5.25M | Sell |
570
-134
| -19% | -$1.29M | ﹤0.01% | 3483 |
|
|
2019
Q3 | $6.69M | Buy |
704
+29
| +4% | +$353K | ﹤0.01% | 3397 |
|
|
2019
Q2 | $10.7M | Buy |
675
+114
| +20% | +$1.89M | ﹤0.01% | 3213 |
|
|
2019
Q1 | $11.6M | Sell |
561
-11
| -2% | -$195K | ﹤0.01% | 3043 |
|
|
2018
Q4 | $6.98M | Buy |
572
+129
| +29% | +$2.24M | ﹤0.01% | 3267 |
|
|
2018
Q3 | $10.9M | Buy |
443
+64
| +17% | +$1.95M | ﹤0.01% | 3199 |
|
|
2018
Q2 | $13M | Sell |
379
-24
| -6% | -$921K | ﹤0.01% | 3109 |
|
|
2018
Q1 | $16M | Buy |
403
+107
| +36% | +$4.06M | ﹤0.01% | 2887 |
|
|
2017
Q4 | $13.6M | Buy |
296
+128
| +76% | +$5.99M | ﹤0.01% | 2979 |
|
|
2017
Q3 | $9.57M | Buy |
+168
| New | +$9.22M | ﹤0.01% | 3192 |
|
Other funds holding KALA
TRCT
BlackRock's KALA Position: Q2 2026 in Review
BlackRock increased its KALA BIO (KALA) stake by 33,021% in Q2 2026, buying an estimated $346K and bringing the position to 71,542 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #4958.
BlackRock first reported a position in KALA in Q3 2017 and has held it in 36 quarters since. The position peaked at $29.6M in Q2 2020. 14 funds tracked by Wall St. Rank hold KALA as of Q2 2026.
- BlackRock held 71,542 shares of KALA BIO worth $124K as of Q2 2026.
- BlackRock bought 71,326 KALA BIO shares in Q2 2026, an estimated $346K.
- KALA BIO made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4958 holding.
- BlackRock first reported a position in KALA BIO in Q3 2017 and has held it in 36 quarters since.
- BlackRock's KALA BIO position peaked at $29.6M in Q2 2020.
- 14 funds tracked by Wall St. Rank held KALA BIO as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.